ANTI-NETRIN-1 ANTIBODY TO TREAT LIVER INFLAMMATION

The netrin-1 protein displays anti-inflammatory activity in the liver and is an unexpected proinflammatory factor in CLD. The present invention provides for blocking or capturing netrin-1 in the liver for treating liver inflammation, and thus methods for treating liver inflammation. To perform this,...

Full description

Saved in:
Bibliographic Details
Main Authors VERZEROLI, Claire, GIBERT, Benjamin, FOURNIER, Carole, MEHLEN, Patrick, PARENT, Romain, BARNAULT, Romain, ZOULIM, Fabien
Format Patent
LanguageEnglish
French
German
Published 20.09.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The netrin-1 protein displays anti-inflammatory activity in the liver and is an unexpected proinflammatory factor in CLD. The present invention provides for blocking or capturing netrin-1 in the liver for treating liver inflammation, and thus methods for treating liver inflammation. To perform this, the invention makes use of a polyclonal or monoclonal antibody specifically binding to netrin-1, including a series of humanized monoclonal antibodies.
Bibliography:Application Number: EP20220305325